| EN

In Yu capital management (Beijing) Limited by Share Ltd

Ch-gemstone capital management (Beijing) Co., Ltd. (hereinafter referred to as "Ch-gemstone capital"), is China first adhering to the "global vision, Chinese opportunity!" Concept, focus on China's medical and health care in the field of equity investment, mergers and acquisitions, debt investment and financing, financial consulting and other services, as well as the professional field of top wealth management financial investment banking services. Until now, in Ch-gemstone capital management and operation of more than 20 health field of equity investment fund, including in  Ch-gemstone Tai Shan,  Ch-gemstone Huangshan,  Ch-gemstone Heng Shan, Yu Jin Zhongkai,  Ch-gemstone new third edition, 7 in venture capital funds, and Aier Ophthalmology, bent hall, prosperous red science and technology, Nanjing high tech, Thai home, Guizhou Yibai, listed companies and institutions combined group 24 buyout fund, the size of the total management to more than 200 billion. Successful investment including Beijing Jialin pharmaceutical, Guangdong Danxia biological, Jiangsu Chen Pai pharmaceutical, Harbin Sanlian pharmaceutical, Sichuan zitonggong pharmaceutical, Anwar Yineng, Beijing Jia Baorenhe, Dalian heart medicine and other international and several pharmaceutical medical enterprises, investment amount of more than 40 billion

 

Our values

Unity, honesty and innovation

We believe that only by adhering to the value of investment in order to create a stable high returns for investors. In the Yu capital investment team has profound medical industry background, more accurate mining and improve the true value of the enterprise. Rich project resources to protect the benchmark value of investment, the investment team has been transferred to nearly 200 companies, long-term follow-up of more than 400
 

Our team

Yu capital management (Beijing) Co., Ltd. (hereinafter referred to as "Yu capital"), is China first adhering to the "global vision, Chinese opportunity!" Concept, focus on China's medical and health care in the field of equity investment, mergers and acquisitions, debt investment and financing, financial consulting and other services, as well as the professional field of top wealth management financial investment banking services. Rich project resources to protect the value of the investment benchmark, the investment team has been adjusted to nearly 200 enterprises, more than 400 long-term tracking Successful investment including Beijing Jialin pharmaceutical, Guangdong Danxia biological, Jiangsu Chen Pai pharmaceutical, Harbin Sanlian pharmaceutical, Sichuan zitonggong pharmaceutical, Anwar Yineng, Beijing Jia Baorenhe, Dalian heart medicine and other international and several pharmaceutical medical enterprises, investment amount of more than 40 billion

Industry background

We believe that only by adhering to the value of investment in order to create a stable high returns for investors. In the Yu capital investment team has profound medical industry background, more accurate mining and improve the true value of the enterprise. Rich project resources to protect the benchmark value of investment, the investment team has been transferred to nearly 200 companies, long-term follow-up of more than 400